Mirum Pharmaceuticals (mirm 4 05/01/29)
13F holders, Q3 2024 (September 30)4holders +2
3new positions
1sold out
$1.47avg. 13F price*
At the end of Q3 2024, 4 institutions reported holding Mirum Pharmaceuticals (mirm 4 05/01/29) in their 13F filings, up 2 from Q2 2024. 3 opened new positions and 1 sold out. The largest holders were Sei Investments Co. ($365K), Oppenheimer Asset Management Inc. ($98K) and Stephens Inc. ($53K).
- Company
- Mirum Pharmaceuticals (mirm 4 05/01/29)
- CUSIP
- 604749AB7
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $154K |
| Exits | 1 | $2.6M |
All 13F filers, Q2 2024 → Q3 2024: 105,000 shares bought and 1,951,000 shares sold, net −1,846,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| Sei Investments Co. | 0.00% | No change | 249,000 | $365K |
| Oppenheimer Asset Management Inc. | 0.00% | New | 67,000 | $98K |
| Stephens Inc. | 0.00% | New | 36,000 | $53K |
| Comerica Bank | 0.00% | New | 2,000 | $3K |
"% of holder's portfolio" is MIRUM PHARMACEUTICALS (MIRM 4 05/01/29)'s weight in each manager's 13F, not the share of Mirum Pharmaceuticals (mirm 4 05/01/29) the manager owns.